StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    This 26-year-old’s blue-collar enterprise brings in .3 million a 12 months
    This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
    9 Min Read
    Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
    Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
    0 Min Read
    3 distinctive funding trusts that would enhance the returns of a Shares and Shares ISA
    3 distinctive funding trusts that would enhance the returns of a Shares and Shares ISA
    4 Min Read
    China shares lag broad Asia rebound,Fed price reduce hopes and Nvidia-Chin
    China shares lag broad Asia rebound,Fed price reduce hopes and Nvidia-Chin
    0 Min Read
    Chinese language corporations chase Africa’s shoppers as useful resource investments plunge 40%
    Chinese language corporations chase Africa’s shoppers as useful resource investments plunge 40%
    9 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    Lloyds Metals & Vitality Ltd – Constructing India’s Subsequent Mining-to-Metals PowerhouseInsights
    Lloyds Metals & Vitality Ltd – Constructing India’s Subsequent Mining-to-Metals PowerhouseInsights
    9 Min Read
    Traders misplaced over 50% good points by lacking the 'finest 3 months'
    Traders misplaced over 50% good points by lacking the 'finest 3 months'
    0 Min Read
    Don't play the ready sport
    Don't play the ready sport
    0 Min Read
    PPFAS plans IPO in 5 years, entry into NPS
    PPFAS plans IPO in 5 years, entry into NPS
    0 Min Read
    Comparable valuations, reverse outcomes
    Comparable valuations, reverse outcomes
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    Is It Truly Value Rs. 3,000?
    Is It Truly Value Rs. 3,000?
    11 Min Read
    Inventory to purchase briefly time period: Axis Securities recommends this PSU inventory as its ‘Decide of the Week’
    Inventory to purchase briefly time period: Axis Securities recommends this PSU inventory as its ‘Decide of the Week’
    6 Min Read
    YES Financial institution Inventory in Consolidation: A Lengthy-Time period Investor’s Perspective
    YES Financial institution Inventory in Consolidation: A Lengthy-Time period Investor’s Perspective
    10 Min Read
    Nifty, Sensex open flat amid optimism of touching contemporary highs: Consultants
    Nifty, Sensex open flat amid optimism of touching contemporary highs: Consultants
    4 Min Read
    Is that this flexi-cap fund getting too huge to shine
    Is that this flexi-cap fund getting too huge to shine
    0 Min Read
  • Trading
    TradingShow More
    Scott Bessent Says If ‘Radical Left’ Once more Shuts Down Authorities In January, GOP Ought to ‘Instantly Finish’ The Filibuster
    Scott Bessent Says If ‘Radical Left’ Once more Shuts Down Authorities In January, GOP Ought to ‘Instantly Finish’ The Filibuster
    3 Min Read
    Mamdani Says He ‘Continues To Imagine’ Every little thing He’d Mentioned Earlier About Trump Regardless of ‘Very Productive’ Assembly
    Mamdani Says He ‘Continues To Imagine’ Every little thing He’d Mentioned Earlier About Trump Regardless of ‘Very Productive’ Assembly
    3 Min Read
    Scott Bessent Says Individuals Set For ‘Lowest Price’ Thanksgiving Dinner In 4 Years After Being ‘Traumatized’ By Biden-Period Costs
    Scott Bessent Says Individuals Set For ‘Lowest Price’ Thanksgiving Dinner In 4 Years After Being ‘Traumatized’ By Biden-Period Costs
    3 Min Read
    The Insider Report: Put together for the Subsequent Dip Shopping for Alternative – Daqo New Power (NYSE:DQ), Dianthus Therapeutics (NASDAQ:DNTH)
    The Insider Report: Put together for the Subsequent Dip Shopping for Alternative – Daqo New Power (NYSE:DQ), Dianthus Therapeutics (NASDAQ:DNTH)
    21 Min Read
    Elon Musk’s Ex-Spouse Shared Insights Into Their Tumultuous Marriage – Tesla (NASDAQ:TSLA)
    Elon Musk’s Ex-Spouse Shared Insights Into Their Tumultuous Marriage – Tesla (NASDAQ:TSLA)
    3 Min Read
Reading: Zydus Life Ahmedabad Unit Clears USFDA Inspection 
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Financial News > Zydus Life Ahmedabad Unit Clears USFDA Inspection 
Financial News

Zydus Life Ahmedabad Unit Clears USFDA Inspection 

StockWaves By StockWaves Last updated: February 15, 2025 4 Min Read
Zydus Life Ahmedabad Unit Clears USFDA Inspection 
SHARE




February 14, 2025February 14, 2025



Zydus Lifesciences Ltd introduced on Friday that america Meals and Drug Administration (USFDA) has efficiently accomplished an inspection of its Ahmedabad facility with none observations.

The US well being regulator inspected the corporate’s Topical Manufacturing web site in Changodar, Ahmedabad, as a part of a routine surveillance inspection carried out between February 10 and February 14. The inspection concluded with zero observations, the corporate said in a press launch.

In the meantime, Zydus Lifesciences reported sturdy monetary efficiency in Q3 FY25. The corporate’s internet revenue surged 30% year-on-year (YoY) to Rs 1,023 crore for the quarter ending December 31, 2024, in comparison with Rs 789 crore in the identical interval final yr. This revenue progress was primarily pushed by a pointy rise in foreign exchange good points, which jumped 771.42% YoY to Rs 183 crore from Rs 21 crore a yr in the past.

The corporate’s income for the December 2024 quarter elevated 17% YoY to Rs 5,269 crore. US formulation gross sales grew 29% YoY to $285 million, surpassing the estimated $270 million, with the US market contributing almost 47% to Zydus Lifesciences’ complete income.

You Would possibly Be In

Moreover, the corporate’s EBITDA rose 25.9% YoY to Rs 1,387 crore in Q3 FY25, up from Rs 1,102 crore within the earlier yr. The EBITDA margin expanded by almost 200 foundation factors (bps) to 26.3% from 24.5% in the identical interval final yr.

Sharvil Patel, Managing Director of Zydus Lifesciences, stated, “Our strong portfolio execution within the US, market share acquire in centered remedy segments and types in India, and strategic leveraging of our international portfolio in worldwide markets place us effectively for future progress.”

At 3:30 pm, the shares of Zydus Lifesciences closed 4.62% decrease at Rs 899.30 on NSE.

Navigate Zydus Lifesciences Like a Professional. Ask the Analyst.

Feeling overwhelmed by the markets? Let Unicorn Indicators be your information. Our user-friendly app simplifies advanced information and supplies actionable buying and selling alerts. Obtain the app at the moment and commerce with confidence!



Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Buyers to Safe Counsel Earlier than Vital Deadline in Securities Class Motion First Filed by the Agency – NMRA ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Buyers to Safe Counsel Earlier than Vital Deadline in Securities Class Motion First Filed by the Agency – NMRA
Next Article BHEL luggage Rs 6,700 crore order from Singareni Collieries BHEL luggage Rs 6,700 crore order from Singareni Collieries
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
This 26-year-old’s blue-collar enterprise brings in .3 million a 12 months
This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
November 24, 2025
Pibit.AI raises M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
Pibit.AI raises $7M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
November 24, 2025
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat
November 24, 2025
Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
November 24, 2025
Is It Truly Value Rs. 3,000?
Is It Truly Value Rs. 3,000?
November 24, 2025

You Might Also Like

Tata Chemical compounds Q1 Outcomes: PAT jumps 80% to Rs 316 crore
Financial News

Tata Chemical compounds Q1 Outcomes: PAT jumps 80% to Rs 316 crore

2 Min Read
Grok AI Coming to Tesla: What to Anticipate
Financial News

Grok AI Coming to Tesla: What to Anticipate

3 Min Read
Telecom inventory in focus after receiving ₹174 Cr order for Telecom Networking Equipments
Financial News

Telecom inventory in focus after receiving ₹174 Cr order for Telecom Networking Equipments

4 Min Read
India, Chile Strengthen Ties with Deal with Essential Minerals & Defence
Financial News

India, Chile Strengthen Ties with Deal with Essential Minerals & Defence

3 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
Pibit.AI raises $7M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up